AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05189379 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcoholic Images
Description: Images of alcoholic items, namely, beer, wine, schnapps are presented in parallel with the alcoholic odour
Study NCT05986760 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SPARK
Description: Functional Motor training
Study NCT05910814 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Description: Participants in the sleep deprivation group will spend a night awake, under the supervision of an investigator, at Croix-Rousse Hospital. The investigator will provide a list of activities to maintain the participant awake.
Study NCT04791345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisone
Description: 12 mg of methylprednisone (3 pills of 4 mg each) administered orally in a single dose.
Study NCT04791345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisone
Description: 12 mg of methylprednisone (3 pills of 4 mg each) administered orally every 24 hours during 3 days.
Study NCT05910814 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Normal Night (Night)
Description: Participants in the normal night group will spend one night sleeping in their own home.
Study NCT06615323 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Polyphonic Lullaby Group
Description: After discharge, mothers will be asked to play the Dandini Dandini Dastana lullaby by vocal artist Mircan Kaya, which they downloaded from the YouTube application, and listen to it from a distance of one meter (away from the baby's head to minimize radioactive effects) and by switching the phone to airplane mode just before sleep. In the event of active sleep (signs of sleep transition such as slowing down muscle movements and closing eyes), the polyphonic lullaby volume will be gradually reduced. The polyphonic lullaby will be played at a volume level of 55 decibels for the first 5 minutes after falling asleep, then reduced to 25 decibels and then turned off. In order to reduce the effects of confounding factors, mothers in the polyphonic lullaby group who use another assistive method (breastfeeding/rocking to sleep) to put their babies to sleep will be excluded from the study.
Study NCT06615323 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pish Pish Sound Group
Description: After discharge, mothers will be asked to turn on the Piş Piş sound downloaded from the YouTube application and listen to it from a distance of one meter (away from the baby's head to minimize radioactive effects) and by turning the phone to airplane mode just before sleep. In case of active sleep (signs of sleep transition such as slowing down muscle movements and closing eyes), the piş piş sound will be gradually reduced. The polyphonic lullaby played will be at a volume level of 55 decibels for the first 5 minutes after falling asleep, then reduced to 25 decibels and then turned off. In order to reduce the effect of confounding factors, mothers in the piş piş sound group who use another assistive method (breastfeeding/rocking to sleep) to put their babies to sleep will be excluded from the scope of the research.
Study NCT05910814 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Exercise (HIIE)
Description: Participants in the physical exercise group (i.e. IM+HIIE, PP+HIIE, SD+PP+HIIE) will start with a 2-minute warm-up on an ergometer cycle.~After the warm-up, they will perform 3 minutes of exercise at a workload customized to their maximal aerobic power (MAP) corresponding to 80 % their MAP and then rest actively for 2 minutes at 40 % of MAP. This cycle of 5 minutes will be repeated 3 times in row, resulting in a total of 17 minutes of physical exercise including the warm-up.
Study NCT06563830 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: educational application
Description: The content of the training to be applied to nurses will include: definition of MDRPI, etiology, prevalence and cost, staging, risk factors, nursing initiatives to be implemented to prevent MDRPI.
Study NCT04976855 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INDV-2000
Description: Capsule for oral administration
Study NCT04976855 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule for oral administration
Study NCT05910814 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rest control
Description: Participants will watch a documentary during an equivalent time as the physical exercise (i.e. 17 minutes).
Study NCT04791345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deflazacort
Description: 30 mg of deflazacort (1 pill) administered orally in a single dose.
Study NCT05910814 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motor imagery
Description: On the bimanual finger tapping task composed of 8 elements, the participant will be required to repeat the motor sequence mentally using MI (mental rehearsal of movement) during twelve blocks of 30 seconds. Participant will imagine performing the sequence as fast and accurately as possible without overt movement.
Study NCT05910814 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Practice (PP)
Description: Participants will practice a bimanual sequential finger tapping task composed of 8 movements. Participant will be required to perform the sequence as fast and as accurately as possible during blocs of 30 s (i.e. twelve blocs during training).
Study NCT05517993 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gui-Lu-Er-Xian-Jiao-Wan
Description: Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) is an ancient CHM formula, mainly originating from processed tortoise shells, antlers, Ginseng, and wolfberry.
Study NCT04791345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 4 mg of dexamethasone (1 pill) administered orally in a single dose.
Study NCT04976855 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SUBOXONE® sublingual film
Description: Administered either under the tongue (sublingual) or between the gum and cheek (buccal)
Study NCT06644404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP16001 0.3mg
Description: 1 tablet, Orally, Once daily single dose
Study NCT06644404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWC202407 1,000mg
Description: 1 tablet, Orally, Twice daily
Study NCT06644404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWC202408 2mg
Description: 1 tablet, Orally, Once daily single dose
Study NCT06612606 — intervention group
Intervention type: OTHER
Intervention: observational study
Description: This was an observational study with no intervention.
Study NCT06615063 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hasi's Splint
Description: A splint made up of cotton and gauze piece rolled over a hard cardboard piece and covered by adhesive tape was applied to the limb immediately after fixing the cannula, as per the standardised method, to prevent movement at the underlying joint. Dimensions of the splints used were standardised as length extending two and a half inches on either side of the joint and width equal to the width of the limb just proximal to the joint.
Study NCT04854486 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GSE and Xylitol
Description: Participants are given the experimental treatment to be used for 7 days.
Study NCT04854486 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control Placebo
Description: Saline
Study NCT04791345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 2 mg of dexamethasone (1/2 pill) administered orally every 12 hours during 5 days.
Study NCT05642533 — intervention group
Intervention type: OTHER
Intervention: No treatment given
Description: No treatment given
Study NCT06644352 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: different thoracic surgical approaches
Description: Right Versus Left Thoracic Surgical Approaches
Study NCT06644352 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: different thoracic surgical approaches
Description: Right Versus Left Thoracic Surgical Approaches
Study NCT05607849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The decidons ensemble (let's decide together) leaflet and the discutons-mammo.fr (let's talk about breast cancer screening) online tool.
Description: The leaflet will include a link to access the discutons-mammo.fr DA aid tool, and will inform women about shared decision-making.~The GPs of women who are sent the leaflet will also be sent a letter encouraging shared decision-making. This material will be sent 3 months after women have received their breast cancer screening invitation letter.~Data related to primary and secondary objectives will be collected by questionnaire from the 2 groups. The questionnaire will be sent 2 months after participants are informed about the tool.
Study NCT05486065 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Semaglutide s.c. injection once-weekly for 40 weeks. Dose gradually increased over 24 weeks, followed by a 16 week maintenance period.
Study NCT05169073 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Virtual Reality training
Description: In the Virtual Reality (VR) study arm, a VR software (Specto VRTM, version 4.0, Diffuse Ltd, Heimberg, Switzerland) will be used to display volumetric MRCP data using a tethered head-mounted display (HMD) prior to the operation. Specto uses volume rendering at 180 frames/sec to visualize the medical data in an immersive fashion in the VR environment and allows for viewing of the 3D reconstructed 3D imaging with 360° free movement. Each participant will perform a procedure with VR training and one with conventional preparation (MRCP).
Study NCT05169073 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional training
Description: In the conventional study arm, the participants will view the preoperative MRCP.
Study NCT05486065 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Semaglutide placebo s.c. injection once-weekly for 40 weeks. Dose gradually increased over 24 weeks, followed by a 16 week maintenance period.
Study NCT06131320 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PVSE Test
Description: Completion of the PVSE test
Study NCT06622941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-4538
Description: every 2 weeks
Study NCT06693739 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Platelet rich fibrin
Description: PRF membrane is placed as a scaffold inside the canal with no hyaluronic acid
Study NCT06693739 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: hyaluronic acid
Description: hyaluronic acid gel is placed as a scaffold inside the canal with no PRF
Study NCT06693739 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: no scaffold
Description: initiate bleeding using hand files size beyond apex with sharp strokes with no PRF or hyaluronic acid placed
Study NCT06613477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PK/PD Model Based Dosing of Digoxin in Infants with Single Ventricle Heart Disease
Description: Table 3: Digoxin dosing regimen based on optimized Cmin,ss Dose to be given twice daily (mcg/kg/dose) PNA\<30 days 30 days \< PNA \< 180 days eGFR≤40 1.4 1.4 40\<eGFR≤60 1.6 1.6 eGFR>60 1.9 2.8
Study NCT06473103 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Two photon fluorescence microscopy imaging
Description: Excised tissues will be imaged with two photon fluorescence microscopy prior to submission for histological processing.
Study NCT06628661 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery for HCC larger than 6.5 cm
Description: Surgery for HCC larger than 6.5 cm without mVI
Study NCT06673823 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mirror therapy
Description: Mirror Therapy (MT) is a non-invasive treatment method aimed at addressing unilateral conditions impacting either the upper or lower limbs. This technique involves placing a mirror along the patient's sagittal plane, allowing the reflection of the unaffected limb to visually overlay the affected limb.
Study NCT06673823 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional therapy
Description: conventional therapy
Study NCT06675279 — intervention group
Intervention type: OTHER
Intervention: Survey-based study
Description: The demographic information of individuals with migraines, along with data from the Visual Analog Scale, Migraine Disability Assessment Questionnaire, Headache Impact Test, Henry Ford Hospital Headache Disability Inventory, and Headache Needs Assessment, will be collected and analyzed.
Study NCT06675422 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JY231 injection
Description: Dose escalation was carried out using the 3+3 principle and the mode of administration was intravenous.
Study NCT06674317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet Delivered Cognitive Behavioral Therapy for Insomnia in Persons with Inflammatory Rheumatic Diseass
Description: Cognitive behavioral therapy for insomnia (CBTi) is considered a first-line treatment for insomnia. Access to this treatment option is limited therefore we have been developing an internet delivered cognitive behavioral therapy for insomnia (I-CBTi) to help overcome accessibility barriers.~The purpose of this study is to pilot test a tailored internet-delivered cognitive behavioral therapy for insomnia (I-CBTi) intervention for persons with Inflammatory Rheumatic Diseases showing symptoms of insomnia.
Study NCT06628661 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery for HCC larger than 2 cm
Description: Surgery for HCC larger than 2 cm with mVI
Study NCT06674317 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Internet Delivered Cognitive Behavioral Therapy for Insomnia in Persons with Inflammatory Rheumatic Diseass
Description: Cognitive behavioral therapy for insomnia (CBTi) is considered a first-line treatment for insomnia. Access to this treatment option is limited therefore we have been developing an internet delivered cognitive behavioral therapy for insomnia (I-CBTi) to help overcome accessibility barriers.~The purpose of this study is to pilot test a tailored internet-delivered cognitive behavioral therapy for insomnia (I-CBTi) intervention for persons with Inflammatory Rheumatic Diseases showing symptoms of insomnia.
Study NCT06675045 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory variability monitoring
Description: Respiratory variability will be measured using a belt equipped with an external sensor allowing automatic and continuous analysis of thoracic movement by frequency analysis
Study NCT05760755 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stick Together
Description: The intervention consists of 12 online modules, completed flexibly during and immediately after primary cancer treatment. The intervention contains interviews with other couples, psychoeducational information, and interactive exercises on themes such as dyadic coping and communication, being diagnosed at a young age, fertility and children, and life after treatment.
Study NCT06698172 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality rehabilitation
Description: The study includes 12 weekly 45-minute visual rehabilitation sessions using a Virtual Reality device with Visionary Sport software. Originally designed for sports visual training, this software features gamified exercises to improve visual response times under professional supervision. Activities include games to enhance fixation, ocular motility, peripheral vision, and vergence.~The Peripheral Attention activity trains reaction times to static stimuli perceived in the peripheral retina, adjustable to the patient's visual field defect. Stimuli can be placed at 10, 20, or 30 degrees in the peripheral field. The VR headset (Vive Focus 3) includes an eye tracker to monitor and adapt stimuli based on patient performance.~Patients also perform 30 minutes of daily exercises at home, using proprietary software and Tobii 4C and 5C eye-tracking devices for ocular monitoring.
Study NCT06696820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitors combined with atorvastatin/rosuvastatin
Description: A single subcutaneous injection of 420 mg Iroceliumab upon admission, along with a standard dose of 20 mg Atorvastatin or 10 mg Rosuvastatin
Study NCT06696820 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Atorvastatin/Rosuvastatin
Description: Conventional Atorvastatin 20 mg / Rosuvastatin 10 mg
Study NCT06697288 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tested product group
Description: Apply the test product per zone at least twice a day on the face, neck (neck \& nape), décolleté and back of the hand in the morning and at midday whatever the weather conditions and the activities of the day
Study NCT06697288 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Maintain their normal routine of using cosmetics (cleansers and moisturizers) and normal sun protection habits (if applicable)
Study NCT06696833 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: QH10304-BAL-01
Description: dose escalation (3+3) : dose 1 (3 × 10\^8cells/kg) ,dose 2 (1 × 10\^9 cells/kg) ,dose 3 (3 × 10\^9cells/kg)
Study NCT06696833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Intravenous fludarabine 30mg/m2 on days-6 to -3,the infusion dose is adjusted according to the subject's condition
Study NCT06696833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Intravenous cyclophosphamide 1000mg/m2 on days -5 to -3, the infusion dose is adjusted according to the subject's condition
Study NCT06697002 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lower trapezius strenghtening excercise
Description: 32 participants will be in control group who will perform strenghtening excerise of lower trapezius
Study NCT04791371 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise
Description: 15 weeks of cardiovascular exercise 3x/week for 50 minutes/session
Study NCT06697002 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: scapular mobility exercise
Description: 32 participants will be in experimental group who will perform scapular mobility exercise
Study NCT06697548 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education
Description: Participants will watch and discuss a short (5-minute) standardized pain neuroscience education video with their treating provider. The video explains and illustrates how chronic pain is different than acute pain in that it concerns nervous system hypersensitivity more than local tissue damage. Pain neuroscience education principles from the video will then be used to throughout all interventions to coach the participants through graded exposure of activities that may have previously been painful or provoked anxiety.
Study NCT06697548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pain Neuroscience Education
Description: Participants will watch and discuss a short (5-minute) standardized pain neuroscience education video with their treating provider. The video explains and illustrates how chronic pain is different than acute pain in that it concerns nervous system hypersensitivity more than local tissue damage. Pain neuroscience education principles from the video will then be used to throughout all interventions to coach the participants through graded exposure of activities that may have previously been painful or provoked anxiety.
Study NCT04610580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN1840
Description: ALXN1840 will be administered orally.
Study NCT06697548 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumbopelvic and Hip Therapeutic Exercise
Description: These motor control exercises will focus on proprioception, coordination, and sensorimotor control training and include progressive exercises that focus on transversus abdominis, lumbar multifidus, diaphragmatic, pelvic floor muscles, and deep hip stabilizers. Exercises will progress from more stabilized (e.g., pelvic tilt, cat and cow) to less stabilized and more dynamic and functional (e.g., forward bending, eccentric squat) to mimic the demands of work duty. Exercise will be trained and progressed during the clinical visits and be performed daily at home.
Study NCT06697548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lumbopelvic and Hip Therapeutic Exercise
Description: These motor control exercises will focus on proprioception, coordination, and sensorimotor control training and include progressive exercises that focus on transversus abdominis, lumbar multifidus, diaphragmatic, pelvic floor muscles, and deep hip stabilizers. Exercises will progress from more stabilized (e.g., pelvic tilt, cat and cow) to less stabilized and more dynamic and functional (e.g., forward bending, eccentric squat) to mimic the demands of work duty. Exercise will be trained and progressed during the clinical visits and be performed daily at home.